Sucampo Pharma, Ltd., a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc. (SPI) has received approval from the Ministry of Health, Labor and Welfare in Japan for Amitiza (lubiprostone), a ...
*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Mallinckrodt Plc said on Tuesday it would spin off its generic drugs business as a separate unit and keep constipation medicine ...
BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) and Abbott (NYSE: ABT) today announced the availability of AMITIZA ® (lubiprostone) in Japan, a prescription medicine ...
First treatment approved for opioid-induced constipation The FDA has expanded the indication for oral lubiprostone (Amitiza) to include opioid-induced constipation in chronic pain patients. The FDA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results